India Cattle Vaccine Market 2024-2030
  • CHOOSE LICENCE TYPE
Consulting Services
    How will you benefit from our consulting services ?

India Cattle Vaccine Market 2024-2030

Last Updated:  Apr 25, 2025 | Study Period: 2024-2030

INDIA CATTLE VACCINE MARKET

 

INTRODUCTION

Additionally, the cattle sector has contributed the most to the expansion of the cattle vaccine industry in recent years.

 

infographics; India Cattle Vaccine Market , India Cattle Vaccine Market Size, India Cattle Vaccine Market Trends, India Cattle Vaccine Market Forecast, India Cattle Vaccine Market Risks, India Cattle Vaccine Market Report, India Cattle Vaccine Market Share

 

The investment in cattle health will continue to be at the top of the agenda for policymakers.

 

However, the companion cattle vaccine market, which primarily includes dogs and cats, is expanding at the fastest rate.

 

In addition, majority of human rabies cases in India are transmitted by dogs, the government has consistently focused on the National Action Plan for Rabies, which aims to vaccinate all dogs in the country.

 

Attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines are among the categories that make up the cattle vaccine market.

 

The market is dominated by attenuated vaccines among these. The most prominent cattle vaccines are the Peste des petits ruminants (PPR) vaccine to combat goat plague, the Brucella vaccine to combat brucellosis, and the Foot and Mouth Disease (FMD) vaccine to protect cattle from FMD as a result of recent government initiatives under the National cattle Disease Control Programme.

 

 

The government has set aside investment for the FMD vaccine program with the goal of containing the disease and eliminating it.

 

The program aims to vaccinate all cattle, buffalo, sheep, goats, and pigs against FMD, as well as all bovine female calves between the ages of 4 and 8 months. Companies in the cattle vaccine industry have benefited greatly from new opportunities brought about by schemes like this one. 

 

INDIA CATTLE VACCINE MARKET SIZE AND FORECAST

 

The India cattle vaccine market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

 

INDIA CATTLE VACCINE MARKETNEW PRODUCT LAUNCH

The indigenously developed vaccine developed by the Indian Council of Agricultural Research (ICAR) against the Lumpy Skin Disease (LSD) virus, which has resulted in the deaths of approximately 50,000 cattle in several states, is expected to be available for purchase in "four to five months."

 

The live attenuated vaccine, which was developed jointly by ICAR's National Research Centre on Equines (NRCE) in Hisar, Haryana, and the Indian Veterinary Research Institute (IVRI) in Izatnagar, Uttar Pradesh, is similar to vaccines for tuberculosis, mumps, rubella, and measles.“

 

It is also homologous, protecting cattle at 100 percent against LSD.At this time, they only administer vaccines against the goat pox and sheep pox viruses.

 

Due to all three viruses belonging to the same genus of capripoxviruses, these heterologous vaccines only provide cattle with cross-protection (up to 70%) against LSD.

 

INDIA CATTLE VACCINE MARKETCOMPANY PROFILE

 

INDIA CATTLE VACCINE MARKETTHIS REPORT WILL ANSWER FOLLOWING QUESTIONS

  1. What is the average cost perIndia cattle vaccine marketright now and how will it change in the next 5-6 years?
  2. Average cost to set up ancattle vaccine marketinIndia?
  3. How manyIndia cattle vaccine marketare manufactured per annum globally? Who are the sub-component suppliers in different regions?
  4. What is happening in the overall public, globally?
  5. Cost breakup of aIndia cattle vaccine marketand key vendor selection criteria
  6. Where is theIndia cattle vaccine market manufactured? What is the average margin per equipment?
  7. Market share ofIndia cattle vaccine marketmanufacturers and their upcoming products
  8. The most important plannedIndia cattle vaccine marketin next 2 years
  9. Details on network of majorIndia cattle vaccine marketand pricing plans
  10. Cost advantage for OEMs who manufactureIndia cattle vaccine marketin-house
  11. 5 key predictions for next 5 years inIndia cattle vaccine market
  12. Average B-2-BIndia cattle vaccine marketprice in all segments
  13. Latest trends inIndia cattle vaccine market, by every market segment
  14. The market size (both volume and value) ofIndia cattle vaccine marketin 2024-2030 and every year in between?
  15. Global production breakup ofIndia cattle vaccine market, by suppliers and their OEM relationship

 

 

 

Sl noTopic
1Market Segmentation
2Scope of the report
3Abbreviations
4Research Methodology
5Executive Summary
6Introduction
7Insights from Industry stakeholders
8Cost breakdown of Product by sub-components and average profit margin
9Disruptive innovation in the Industry
10Technology trends in the Industry
11Consumer trends in the industry
12Recent Production Milestones
13Component Manufacturing in US, EU and China
14COVID-19 impact on overall market
15COVID-19 impact on Production of components
16COVID-19 impact on Point of sale
17Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
18Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
19Market Segmentation, Dynamics and Forecast by Application, 2024-2030
20Market Segmentation, Dynamics and Forecast by End use, 2024-2030
21Product installation rate by OEM, 2023
22Incline/Decline in Average B-2-B selling price in past 5 years
23Competition from substitute products
24Gross margin and average profitability of suppliers
25New product development in past 12 months
26M&A in past 12 months
27Growth strategy of leading players
28Market share of vendors, 2023
29Company Profiles
30Unmet needs and opportunity for new suppliers
31Conclusion
32Appendix